Trypanosoma brucei brucei
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| I7BA80 | Haptoglobin-hemoglobin receptor |
|
2 | 0 |
|
| Q99279 | Receptor-type adenylate cyclase GRESAG 4.1 |
|
11 | 0 |
|
| P06016 | Variant surface glycoprotein ANTAT 1.1C (Fragment) |
|
3 | 0 |
|
| P26328 | Variant surface glycoprotein ILTAT 1.23 |
|
3 | 0 |
|
| Q99280 | Receptor-type adenylate cyclase GRESAG 4.3 |
|
5 | 0 |
|
| P26332 | Variant surface glycoprotein MITAT 1.2 |
|
2 | 0 |
|
| B3GVK1 | Variant surface glycoprotein |
|
2 | 0 |
|
| Q26721 | Receptor-type adenylate cyclase ESAG 4 |
|
8 | 0 |
|
| Q8WPU1 | Transferrin receptor subunit ESAG6 |
|
5 | 0 |
|
| P26326 | Variant surface glycoprotein ILTAT 1.21 |
|
3 | 0 |
|
| P86935 | GPI mannosyltransferase 3 |
|
2 | 0 |
|
| P26334 | Variant surface glycoprotein MITAT 1.6 |
|
1 | 12 |
|
| P14043 | Procyclic form-specific polypeptide |
|
1 | 0 |
|
| P04477 | VSG expression site-associated protein 117A |
|
3 | 0 |
|
| P26327 | Variant surface glycoprotein ILTAT 1.22 |
|
2 | 0 |
|
| Q01889 | Protein PAG1 |
|
4 | 0 |
|
| P06017 | Variant surface glycoprotein ANTAT 1.8 (Fragment) |
|
1 | 0 |
|
| Q8WPU2 | Transferrin receptor subunit ESAG7 |
|
3 | 0 |
|
| P26329 | Variant surface glycoprotein ILTAT 1.24 |
|
1 | 0 |
|
| P04478 | VSG expression site-associated protein 221A |
|
3 | 0 |
|
| P06014 | Variant surface glycoprotein ILTAT 1.3 |
|
2 | 0 |
|
| P06015 | Variant surface glycoprotein AnTaT 1.1 |
|
3 | 0 |
|
| P26333 | Variant surface glycoprotein MITAT 1.5 |
|
3 | 0 |
|
| P26330 | Variant surface glycoprotein ILTAT 1.25 |
|
2 | 0 |
|
| P14658 | Cysteine proteinase |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025